SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)

Jun 21, 2023

2. SEC Identification Number

148022

3. BIR Tax Identification No.

000-288-655-000

4. Exact name of issuer as specified in its charter

Euro-Med Laboratories Phil., Inc.

5. Province, country or other jurisdiction of incorporation

Metro Manila

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

PPL Building, United Nations Avenue corner San Marcelino St., Manila Postal Code 1007

8. Issuer's telephone number, including area code

00-63-2-85240091 to 98

9. Former name or former address, if changed since last report

N/A

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
common shares	4,112,140,540

11. Indicate the item numbers reported herein

Item 9 : Other Events

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Euro-Med Laboratories Phil., Inc.EURO

PSE Disclosure Form 4-25 - Results of Organizational Meeting References: SRC Rule 17 (SEC Form 17-C) and
Section 4.4 of the Revised Disclosure Rules

Subject of the Disclosure
Results of the Organizational Meeting of the Board of Directors
Background/Description of the Disclosure
The Board of Directors of Euro-Med Laboratories Phil., Inc. (the “Corporation”) held its Organizational Meeting today, 21 June 2023 at the Corporation’s Training Room at the 4th Floor of PPL Building, immediately after the 2023 Annual Shareholders’ Meeting.

List of elected officers for the ensuing year with their corresponding shareholdings in the Issuer

Name of Person	Position/Designation	Shareholdings in the Listed Company		Nature of Indirect Ownership
		Direct	Indirect
Dr. William G. Padolina	Chairman of the Board	20,564	0	-
Mr. Basilio C. Yap	Vice Chairman	20,564	1,755,190	owns a share from the majority stockholder
Mr. Edwin D. Feist	Vice Chairman	11,607	0	-
Mrs. Georgiana S. Evidente	President	1,285,052	0	-
Mr. Johnny C. Yap	EVP/Treas/Asst. Corp. Sec.	36,980,720	568,393	owns a share from the majority stockholder
Evangeline V. Baviera, M.D.	Executive Vice President	41,645	0	-
Mrs. Janice R. Ong	Corp Sec & Investor Relations Officer	51,410	0	-
Mr. Jose A. Emiterio	SVP & Compliance Officer	205,610	0	-
Mr. Enrique Raymond I. Yap	Senior Vice President	16,862,581	371,844	owns a share from the majority stockholder
Mrs. Rosanna Marie S. Suñga	Vice President	20,564	0	-
Mrs. Isleen Y. Sy	Vice President	0	0	-
Mrs. Dinah D. Trivilegio	Vice President	4,116	0	-
Mr. Virgilio V. Leyeza, Jr.	Vice President	41,126	0	-
Mrs. Ma. Bernadette M. Doctor	Asst. Treasurer	20,564	0	-
Atty. David Michael O. Gabriel	Data Protection Officer & Legal Counsel	0	0	-
Mrs. Sandra N. Pineda	Chief Accountant	0	0	-

List of Committees and Membership

Name of Committees	Members	Position/Designation in Committee
Corporate Governance and Nomination Committee	Dr. William G. Padolina	Chairman (Independent Director)
Corporate Governance and Nomination Committee	Mr. Edwin D. Feist	Member (Independent Director)
Corporate Governance and Nomination Committee	Esperanza I. Cabral, M.D.	Member (Independent Director)
Corporate Governance and Nomination Committee	Dr. Johnny C. Yap	Member
Corporate Governance and Nomination Committee	Mrs. Georgiana S. Evidente	Member
Audit and Risk Oversight Committee	Mr. Edwin D. Feist	Chairman (Independent Director)
Audit and Risk Oversight Committee	Dr. William G. Padolina	Member (Independent Director)
Audit and Risk Oversight Committee	Mr. Anthony Joseph Y. Gaw	Member

List of other material resolutions, transactions and corporate actions approved by the Board of Directors
None
Other Relevant Information
None